Europe PMC
open access
Population pharmacokinetics of child-friendly dispersible amoxicillin/clavulanate tablets in African children with severe community acquired pneumonia
Background Severe community-acquired pneumonia (CAP) remains a leading cause of mortality in children under five. The PediCAP trial evaluated oral step-down therapy using dispersible amoxicillin or amoxicillin/clavulanate tablets in African children hospitalised with severe CAP. Dispersibl
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi#814007
- Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia#1486309
- Antibiotic Therapy In Respiratory Tract Infections#1436815
- Acquired pneumonia in the community lethality and their relationship with the stratification process, the fulfillment of suggestions about intrahospitalary location and the antimicrobial initial treatment#948655
- Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults#831061
Record · ID 1492200
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive